InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Monday, 07/13/2020 1:18:40 AM

Monday, July 13, 2020 1:18:40 AM

Post# of 16706
Yes selling the BTH FAIMS proprietary research to BLO was discussed. Also due to SK's success in the COVID fight there is a delay but it appears Novotech, our CRO, is working on that AWAP. They are in process of recruiting the IPF / CC trials which were the original target of NP-120 before COVID.
COVID is Rampant in much of the US and we have a separate CRO coordinating the N America arm of the Multinational trial2b/3. Novotech is working in the Philippines and Dr, Mark has contacts in E Eu... 2b/3 trials have a good momentum, IMO.
Really, this is an OTC stock with a checkered history. Long time shareholders may be rewarded as well as newcomers. Everyone should decide their own Risk to Reward ratio, IMO. Plenty of new DD has been posted, I suggest reading the whole Lancet article for perspective on IPF/CC/COVID and where we might fit in...GLTA...